Intervention

Nicotine gum

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting1

Common conditions12

Lead sponsors shown3

Clinical trials

3 shown

Evaluating Smoking Cessation Interventions for PWH in South AfricaNCT05413122 · 2023-11-27

RECRUITING

Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health SettingsNCT05030272 · 2021-09-21

COMPLETED

The Effects of Nicotine Chewing Gum in Parkinson's DiseaseNCT02452125 · 2015-05-01

COMPLETED

Common conditions

Bipolar Disorder1 Comorbidities and Coexisting Conditions1 HIV1 Low Blood Pressure1 Mental Illness1 Parkinsons Disease1 Persistent Depressive Disorder1 Recurring Major Depressive Disorder1 Schizoaffective Disorder1 Schizophrenia1 Smoking Cessation1 Tobacco Use Disorder1

Leading sponsors

Johns Hopkins University 1 New York Institute of Technology 1 Wake Forest University Health Sciences 1

Trial status mix

COMPLETED2

RECRUITING1

Phase mix

NA2

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.